HSIC•Henry Schein raised its 2026 non-GAAP diluted EPS guidance to $5.50-$5.56 from $5.29-$5.39, citing tariff refunds and improved underlying performance. Tariff refunds contributed $0.19 per diluted share, while underlying adjusted EPS rose 19.1%.
Henry Schein raised its 2026 non-GAAP diluted EPS guidance to $5.50-$5.56 from $5.29-$5.39. Tariff refunds contributed $0.19 per diluted share, and underlying adjusted EPS increased 19.1%, excluding refunds and the prior-year remeasurement gain.
US dental merchandise sales increased 8.6%, including 7% internal local-currency growth driven primarily by volume-based market share gains. Management maintained its $125 million operating income improvement exit run-rate target and expressed confidence in double-digit earnings growth in 2027.
